Reinhard Dummer, Prof. Dr. med - Making the Case for a Systemic Approach to Advanced Basal Cell Carcinoma: A Multidisciplinary Team Strategy to Optimize Long-Term Care

episode

CME in Minutes: Education in Oncology & Hematology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

5 year plans don't work. Here's how to build a routine that actually helps you achieve your goals with Dr Rangan Chatterjee 23 min · 21 Sep 2026 · Working Hard with Grace Beverley

Kylie! – Michael Hutchence, ‘Indie Kylie’ and those gold hotpants 1h 3m · 21 Sep 2026 · Talk ’90s to me

Whateley in a Snapshot | Monday (21.09.26) 6 min · 21 Sep 2026 · Whateley

Being trans in Britain in 2026 29 min · 21 Sep 2026 · Today in Focus

The Mormon Founding of Salt Lake City 51 min · 21 Sep 2026 · American History Hit

‘Lanterns’ Episode 6 Instant Reactions | The Midnight Boys 1h 35m · 21 Sep 2026 · The Ringer-Verse

Report any issue

Source

Recorded30 Mar 2023

Publisherc.answersincme.com ↗

Handlerec:766091

Show notes

Please visit answersincme.com/BRY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses current and emerging strategies to optimize the multidisciplinary care of advanced basal cell carcinoma (BCC) with immunotherapy.Upon completion of this activity, participants should be better able to: Identify patients with BCC for whom a second-line immunotherapy regimen would be appropriate; Review the clinical profiles of immunotherapy-based regimens for the second-line treatment of advanced BCC; and Outline multidisciplinary strategies to optimize the long-term care of patients with advanced BCC who are on an immunotherapeutic approach.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in